Kos J - Search Results

1

Different glycosylation profiles of cystatin F alter the cytotoxic potential of natural killer cells.

Senjor E, Pirro M, Švajger U, Prunk M, Sabotič J, Jewett A, Hensbergen PJ, Perišić Nanut M, Kos J. Senjor E, et al. Among authors: kos j. Cell Mol Life Sci. 2023 Dec 13;81(1):8. doi: 10.1007/s00018-023-05041-x. Cell Mol Life Sci. 2023. PMID: 38092995 Free PMC article.

2

Cystatin F Affects Natural Killer Cell Cytotoxicity.

Perišić Nanut M, Sabotič J, Švajger U, Jewett A, Kos J. Perišić Nanut M, et al. Among authors: kos j. Front Immunol. 2017 Nov 13;8:1459. doi: 10.3389/fimmu.2017.01459. eCollection 2017. Front Immunol. 2017. PMID: 29180998 Free PMC article.

3

Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.

Perišić Nanut M, Sabotič J, Jewett A, Kos J. Perišić Nanut M, et al. Among authors: kos j. Front Immunol. 2014 Dec 2;5:616. doi: 10.3389/fimmu.2014.00616. eCollection 2014. Front Immunol. 2014. PMID: 25520721 Free PMC article. Review.

4

Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F.

Magister Š, Tseng HC, Bui VT, Kos J, Jewett A. Magister Š, et al. Among authors: kos j. Oncotarget. 2015 Sep 8;6(26):22310-27. doi: 10.18632/oncotarget.4208. Oncotarget. 2015. PMID: 26247631 Free PMC article.

5

Cystatin F as a regulator of immune cell cytotoxicity.

Kos J, Nanut MP, Prunk M, Sabotič J, Dautović E, Jewett A. Kos J, et al. Cancer Immunol Immunother. 2018 Dec;67(12):1931-1938. doi: 10.1007/s00262-018-2165-5. Epub 2018 May 10. Cancer Immunol Immunother. 2018. PMID: 29748898 Free PMC article. Review.

6

Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells.

Prunk M, Nanut MP, Sabotic J, Svajger U, Kos J. Prunk M, et al. Among authors: kos j. Radiol Oncol. 2019 Mar 3;53(1):57-68. doi: 10.2478/raon-2019-0007. Radiol Oncol. 2019. PMID: 30840596 Free PMC article.

7

Multiple Defects of Natural Killer Cells in Cancer Patients: Anarchy, Dysregulated Systemic Immunity, and Immunosuppression in Metastatic Cancer.

Jewett A, Kos J, Kaur K, Turnsek TL, Breznik B, Senjor E, Wong P, Nguyen KY, Ko MW. Jewett A, et al. Among authors: kos j. Crit Rev Immunol. 2020;40(2):93-133. doi: 10.1615/CritRevImmunol.2020033391. Crit Rev Immunol. 2020. PMID: 32749091 Review.

8

Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity.

Prunk M, Perišić Nanut M, Jakoš T, Sabotič J, Švajger U, Kos J. Prunk M, et al. Among authors: kos j. Cancers (Basel). 2020 Dec 6;12(12):3660. doi: 10.3390/cancers12123660. Cancers (Basel). 2020. PMID: 33291222 Free PMC article.

9

Cystatin F acts as a mediator of immune suppression in glioblastoma.

Senjor E, Perišić Nanut M, Breznik B, Mitrović A, Mlakar J, Rotter A, Porčnik A, Lah Turnšek T, Kos J. Senjor E, et al. Among authors: kos j. Cell Oncol (Dordr). 2021 Oct;44(5):1051-1063. doi: 10.1007/s13402-021-00618-9. Epub 2021 Jun 29. Cell Oncol (Dordr). 2021. PMID: 34189679

10

Human CD4+ T-Cell Clone Expansion Leads to the Expression of the Cysteine Peptidase Inhibitor Cystatin F.

Perišić Nanut M, Pawelec G, Kos J. Perišić Nanut M, et al. Among authors: kos j. Int J Mol Sci. 2021 Aug 5;22(16):8408. doi: 10.3390/ijms22168408. Int J Mol Sci. 2021. PMID: 34445118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page